Therapeutic or prophylactic agent for corneal epithelium disorders and/or conjunctival epithelium disorders
The present invention provides an effective and safe prophylactic and therapeutic pharmaceutical agent and supplement for corneal epithelium disorders and/or conjunctival epithelial disorders. This is a therapeutic and/or prophylactic agent for corneal epithelium disorders and/or conjunctival epithe...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
12.10.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention provides an effective and safe prophylactic and therapeutic pharmaceutical agent and supplement for corneal epithelium disorders and/or conjunctival epithelial disorders. This is a therapeutic and/or prophylactic agent for corneal epithelium disorders and/or conjunctival epithelial disorders comprising eicosapentaenoic acid and/or docosahexaenoic acid, a glycerin ester or phospholipid comprising these fatty acids as constituent fatty acids, or a lower alcohol ester of these fatty acids as active ingredients. These preferably comprise EPA and/or DHA in the form of a refined fish oil or refined krill oil. A total of at least approximately 50 to 5,000 mg of EPA and/or DHA or the esters thereof are taken daily, thereby easing corneal epithelium disorders and/or conjunctival epithelial disorders. In addition, the amount of tears may be recovered.
本发明提供了对角膜上皮病变和/或结膜上皮病变有效且安全的预防和治疗药品或补充剂。具体而言,本发明提供了种用于角膜上皮病变和/或结膜上皮病变的治疗剂或预防剂,其特征在于包含如下物质作为活性成分:二十碳五烯酸和/或二十二碳六烯酸、含有所述脂肪酸作为组成脂肪酸的甘油酯或磷脂,或所述脂肪酸的低级醇酯。优 |
---|---|
Bibliography: | Application Number: CN201610474982 |